Janux Therapeutics, Inc. (JANX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Janux Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.53x | -41.71x | -8.10x | -8.66x | -24.91x | -154.26x |
| P/B Ratio | 0.89x | 2.81x | 1.37x | 1.70x | 2.22x | -71.49x |
| P/S Ratio | 85.51x | 271.80x | 58.43x | 63.42x | 223.74x | 0.00x |
| Profitability | ||||||
| Gross Margin | 79.7% | 80.5% | 75.8% | 90.2% | 100.0% | 0.0% |
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | 0.0% |
| Net Margin | -1136.3% | -651.6% | -721.2% | -732.2% | -898.3% | 0.0% |
| EBITDA Margin | -1116.0% | -914.1% | -878.7% | -769.3% | -902.3% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 39.04x | 59.21x | 26.80x | 20.14x | 29.46x | 5.05x |
| Quick Ratio | 39.04x | 59.21x | 26.80x | 20.18x | 29.46x | 5.05x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.07x | 0.08x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..